This page includes the latest FDA filings for Altor Bioscience L L C An Indirect Wholly Owned Subsidiary Of Immunitybio Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc., Ajinomoto Bio-Pharma Services | Prescription Medication | 2024-05-11 |